Otonomy to Present at the J.P. Morgan Healthcare Conference

Back to Jobs

SAN DIEGO , Jan. 02, 2019 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber , Ph.D., president and chief executive officer, will present at the 37 th Annual J.P.

Apply Now